In this chemiluminescence enzyme immunoassay for thyroxin, glucose oxidase (EC 1.1.3.4) is the enzyme label and the bound and free fractions are separated by the doubleantibody solid-phase technique. In the assay of enzyme activity, hydrogen peroxide generated from glucose substrate is measured by its chemiluminescence reaction with bis(2,4,6-tnchlorophenyl)oxalate and 8-anilino-1-naphthalenesulfonic acid. The measurable range of thyroxin is 2.5 to 200 gIL. The coefficients of variation for thyroxin concentrations of 43.2and 12.8 j.g/L were 7.0% and 8.6% (intra-assay), and 6.4% and 12.3% (interassay), respectively. The proposed method is applicable to large-scale preliminary screening of neonates for congenital hypothyroidism, with samples consisting of dried blood spotted on filter paper. The prevalence of congenital hypothyroidism is approximately one in 4000 live births (1). Current procedures used in mass screening for congenital hypothyroidism in neonates usually consist of radioimmunoassay (RIA) for TSH or T4, or both, in blood spotted on filter paper and dried (2) . ' Although RIA is a sensitive, simple method for detecting the small amounts of TSH and T4 in such samples, problems with disposal and radiation hazards of isotopes make nonisotopic methods desirable in routine mass-screening.
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The prevalence of congenital hypothyroidism is approximately one in 4000 live births (1). Current procedures used in mass screening for congenital hypothyroidism in neonates usually consist of radioimmunoassay (RIA) for TSH or T4, or both, in blood spotted on filter paper and dried (2) . ' Although RIA is a sensitive, simple method for detecting the small amounts of TSH and T4 in such samples, problems with disposal and radiation hazards of isotopes make nonisotopic methods desirable in routine mass-screening.
Using j3-o-galactosidase, we have developed a fluorescence enzyme immunoassay (EIA) for TSH that is applicable to such samples (3). Miyai et al. (4) and Ishikawa and Kato (5) also have developed fluorescence EIAs for TSH with f3-o-galactosidase as the label enzyme. Since 1982, all of these EIAs for TSH have been put to use in routine large-scale screening for congenital hypothyroidism in Japan. However, measurement of either TSH or T4 alone may fail to identif' all affected patients; both should be measured in mass screening.
Since the development of homogeneous EIA for T4 by Ullman et al. (6) , several EIA methods for T4 (7-Il) have been reported, and commercial kits for determining T4 in serum samples have become available. However, most of them do not accurately measure T4 in dried blood spots on ifiter paper. We previously reported (12) the development of a fluorescence EIA for T4, with peroxidase as the label enzyme. Although the sensitivity of this method sufficed to determine T4 in a dried blood spot on ifiter paper, the doseresponse curve was not steep, because of the high nonspecific binding of T4-peroxidase conjugate on the double-antibody solid-phase, and the values for T4 obtained by the Four thyroxin-BSA conjugates were prepared and the number of T4 residues conjugated to BSA in each procedure was determined spectrophotometrically.
T4.-BSA-ECDI was prepared by the method of Alexander and Jennings (15) .
To prepare T4-BSA-glutaraldehyde we dissolved 50 mg of BSA in 10 mL of a 6 mol/L solution of guanidine HC1 in phosphate buffer (100 mmol/L, pH 8.0). To this solution 102 mg of T4-methyl ester hydrochloride, dissolved in 3 mL of dimethyl formamide, was added dropwise at 0 #{176}C. Then 65 p.L of 100 mLIL glutaraldehyde solution was added to this reaction mixture three times over a 15-win period, giving a total of 195 pmol of glutaraldehyde, and incubated for 1 h in a bath of ice-water. We then dialyzed the reaction mixture twice against 4 L of sodium carbonate buffer (50 mmol/L, pH 9.0) and then four times against water, and lyophilized the dialysand.
We prepared T4-hemiglutarate--BSA and T4-hemisuccinate-BSA conjugates by the active ester method as follows. T4-hemiglutarate or T4-hemisuccinate (250 mol), N-hydroxysuccinimide (250 /Lmol), and dicyclohexylcarbodiimide (275 .anol) were dissolved in 2.5 mL of dioxane, with stirring, at 4 #{176}C. After incubation overnight at 4#{176}C, the precipitated urea was separated by centrifugation. After removing and evaporating the supernatant fluid, we dissolved the resulting residue in 3 mL of dioxane and added dropwise, at 4#{176}C, 200 mg of BSA dissolved in 20 mL of phosphate buffer (50 mmol/L, pH 8.0). After stirring the reaction mixture gently overnight at 4 #{176}C, we dialyzed it against two successive 4-L portions of sodium carbonate buffer (50 mmolJL, pH 9.0), then four times against water, before lyophilization.
The number ofT4 residues conjugated to BSA in T4-BSA-ECDI, T4-BSA-glutaraldehyde, and T4-hemisuccinate-BSA were 17, 13, and 20, respectively. The T4 residues in T4-hemiglutarate-BSA could not be determined because of the coloration of the sample.
Thyroxin-glucose
oxidase conjugates. Four T4-glucose oxidase conjugates were prepared by the same procedures described above. Details were as follows.
T4-glucose oxidase-ECDI: Four milligrams of T4 (free acid) was dissolved in 0.6 mL of 95% dimethylformamide by stirring for 30 mm. To this solution, we added 1 mL of a 10 mg/mL glucose oxidase solution in water and 2.6 mg of ECDI and stirred for 30 mm. One milliliter of a 20 mglmL solution of ECDI in water was added after a further 20 mm, 3 h, and 4 h. The mixture was then incubated overnight at 4#{176}C. After dialysis against phosphate buffer (50 mmol/L, pH 7.0), the product was chromatographically purified on a 1 x 50 cm column of Toyopeal 11W 55, with phosphate buffer (50 mmol/L, pH 7.0) as eluent. We collected 1-mL fractions of the eluate for assay by spectrophotometry and by the immunoassay described below. Fractions found to have high activity were pooled, diluted fourfold with phosphate buffer (50 mmo]JL, pH 7.0) containing 9 g of NaCl and 1 g of BSA per liter, and stored at 4 #{176}C until use.
T4-glucose oxidase-glutaraldehyde: We dissolved 3 mg of T4-methyl ester HC1 in 1 mL of dimethylformamide and mixed this with 1 mL of glucose oxidase solution in water (10 mg/mL). To this solution we added 0.2 mL of 10 mIJL glutaraldehyde solution incubated for 2 h at room temperature. The product was purified (dialysis and chromatographic separation) as described above.
T4-hemisuccinate-glucose oxidase and T4-hemiglutarateglucose oxidase: After dissolving 5 mg of T4-hemisuccinate or T4-hemiglutarate in 1 mL of 95% dioxane, we mixed in 1 mL of a 10 mg/mL aqueous solution of glucose oxidase. To this we added ECDI, as in the preparation of T4-glucose oxidase-ECDI described above. About two T4 residues were conjugated to glucose oxidase in each of these preparations, as measured by spectrophotometric determination. Antisera to T4. We raised antisera to each of the four T4-BSA conjugates by injecting 1 mg of each in an equal volume of complete Freund's adjuvant emulsion at 20 intradermal points on female rabbits weighing approximately 3 kg. Such injections were given each week for the first two months. Two months after the primary immunization, and each month subsequently, animals were re-injected with 0.3 mg of immunogen and the antibody titers of blood samples were determined. We used RIA to select the antisera with the best sensitivity and specificity, with ['251]T4 as tracer.
Standard solution of T4. One milligram ofT4 (free acid) was suspended in water, dissolved by adding 20 pL of 1 mol/L NaOH solution, and then diluted to 100 pg/mL with water. This solution was stable for one week at 4#{176}C.
Standard dried blood disc of T4. T4-free serum was prepared by removing T4 from pooled human serum by charcoal treatment (7) . Erythrocytes from apparently normal heparinized blood were washed twice with isotonic saline, once with T4-free serum, and then recombined with T4-free serum to adjust the hematocrit to 55%, to mimic the higher hematocrit in newborns. We added known amounts of T4 to give final concentrations of 0, 2.5, 5.0, 10, 25, 50, 100, and 200 g/L in whole blood. These T4 blood standards were then spotted on ifiter paper to serve as standards for the dried blood on discs.
Double-antibody solid-phase beads. These beads were prepared as reported elsewhere (15) .
Goat anti-rabbit IgG was purified by affinity chromatography on a column packed with rabbit IgG-Sepharose 4B, then diluted with phosphate buffer (50 mmolJL, pH 7.4) to 22 g/mL. After polyacetal beads (cogwheel type, 6 mm in diameter and 6 mm thick) were immersed overnight in the diluted goat anti-rabbit IgG solution at room temperature, the antirabbit IgG-coated beads were coated with 3 g/L BSA-saline solution for 1 h at room temperature and stored at 4#{176}C until used. Just before use, the beads were washed with phosphate buffer (50 mmolfL, pH 7.0) containing 9 g of NaCl and 1 g of BSA per liter.
Procedures

Optimization
of T4-EIA assay conditions.
We used barbital buffer (120 mmolJL, pH 8.6), containing 1 g of BSA per liter, for the assay. To each assay tube add, in order, 100 L each of anti-T4 antiserum, T4 standard (10-2500 ngfL), and T4-glucose oxidase solution, mix well, then add one DASP bead and incubate overnight at 4#{176}C. After incubation, aspirate and discard the reaction solution, and wash the bead three times with isotonic saline before using the following chemilurninescence assay.
Chemiluminescence assay for glucose oxidase activity. This assay was done as described previously (19). In brief: to the assay tube containing the washed DASP bead, add 300 tL of glucose substrate solution and incubate overnight at 4#{176}C. After incubation, add 100 pL of the reaction solution and 200 pL of'rcpo solution to the glass test tube containing 100 L of ANS solution, then measure the chemiluminescence intensity for the 6-s interval from 15 to 21s after mixing the reagents. (We used an Aloka Luminescence Reader, Aloka Co., Tokyo, Japan.) T4-EIA method for mass screening.
The buffer for the assay contains, per liter, 120 j.mol of barbital (pH 8.6), 1 g of BSA, and 0.4 g of ANS. Assay all standards and samples in duplicate, using 3 mm-diameter discs punched out from dried blood samples spotted on filter paper. Place one disc of dried blood sample or standard disc in each assay tube, then add to each tube, in the order named, 200 L of anti-T4-hemiglutarate-BSA antiserum diluted 105-fold, 100 L of T4-glucose oxidase-glutaraldehyde solution (diluted 2000-fold), and one double-antibody solid-phase bead to each assay tube. Incubate for 3 h at 37#{176}C, then remove the reaction solution and filter paper disc. Wash the bead and determine its glucose oxidase activity by the chemiluminescence method described above.
Radioimmuno#{231}issay of T4. Using the same barbital assay buffer as in the chemiluminescence assay, combine 100 L of diluted anti-T4 antiserum, 100 pL of T4 standard solution with assay buffer, and stir overnight at 4#{176}C. Then add 2 mL of isotonic saline and centrifuge at 2000 rpm for 3 miii. Aspirate the supernate and wash the precipitated immunesorbent twice with 2-mL portions of isotonic saline. Count the radioactivity bound to the tube (we used an Aloka Model 6500 gamma spectrometer).
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Radioimmunoassay of T4 in dried blood discs. We used a commercial RIA kit (Autopack Neonatal-T4#{174}, Micromedic Inc., Horshain, PA) to measureT4 in dried blood samples on ifiter paper.
Results
Analytical Variables
Sensitivity.
To determine what influences the sensitivity of the T4-EIA, we synthesized various T4-BSA and T4-glucose oxidase conjugates and ascertained the titer of an antiserum by its ability to bind a certain amount of ['I]T4. The antisera we used were those with the highest sensitivity in immunization time, and the highly immunologically active fractions of the T4-glucose oxidase conjugates were selected for the assay. Typical dose-response curves of T4 for homologousand heterologous systems are shown in Figure   1 . The results of all combinations between anti-T4 antisera and T4-glucose oxidases are summarized in Table 1 . The bridge heterologous system with anti-T4-hemiglutarate--BSA antiserum and T4-glucose oxidase prepared by glutaraldehyde method is the most sensitive of all the combinations tested.
The affinities of anti-T4 sera determined by RIA with ['ITF4 tracer are also illustrated in Table 1 .
Specificity.
We assessed the specificities of antiserum . ---#{149}---.---.--.---#{149}-#{149}- ..--
T4-W (Ecu). T4-g-.
against T4-hemiglutarate-BSA with T4-glucose oxidases prepared with glutaraldehyde (bridge heterologous system) and with ECDI (site heterologous system). Table 2 lists the cross reactivities of these antisera with seven kinds of T4-related compounds.
Optimization studies.
To establish the optimal standard method of EJA for T4 in dried blood samples, we examined what dilutions of anti-T4 antiserum and T4-glucose oxidase conjugate yielded optimal chemiluminescence intensity. Although the chemiluminescence at B0 decreased with increasing dilution of antiserum, the sensitivity of the assay increased; however, increasing the dilution also decreased precision because of a decrease in the amount of T4-glucose oxidase bound to the double-antibody solid-phase bead. As a compromise between sensitivity and precision, we used iOnfold dilutions of anti-T44iemiglutarate-BSA antiserum for the assay. Increasing the dilution of the T4-glucose oxidase solution improved assay sensitivity, but chemiluminescence intensity at B0 decreased, as did the precision of the assay. As a compromise between sensitivity and precision, we chose to use 2000-fold diluted T4-glucose oxidase prepared with glutaraldehyde.
Standard curve. Figure 2 shows a typical standard curve for T4, prepared from data on T4 standards in dried blood discs. The coefficient of variation (CV) for each point ranged from 2.1% to 4.8% (mean 2.8%). The limit of detection forT4 (i.e., the response distinguishable from that for no T4) was 2.5 g/L, equivalent to 5 pg (6.43 fmol) per disc.
Effect of dilution
of eluates from dried blood spots. We investigated the effect of dilution of dried blood samples, as a Table 2 
14-GO (G)
Prepared by glutaraldehyde method (bridge heterologous).
b Prepared by ECDImethod (siteheterologous). GO, glucose oxidase. step in assessing the accuracy of the proposed T4 EJA method. We serially diluted eluates from two different samples of dried blood containing different amounts of T4 with the eluate from discs of T4-free dried blood and determined their 'F4 concentrations. As shown in Figure 3 , the dilution curve is linear and passes through the origin.
Precision
studies.
Intra-and interassay precision (CV) were evaluated by testing five replicates each of high and low T4 concentrations in dried blood samples. Analysis of these discs on the same day gave mean values of 12. EJA for 17a-hydroxyprogesterone, using glucose oxidase as the label enzyme. To assay enzyme activity after separating the bound and free fractions, we measured the hydrogen peroxide generated from glucose substrate by the chemiluminescence reaction of bis(2,4,6-trichlorophenyl)oxalate and the fluorescent dye (ANS). Given the success of that method for large-scale screening for congenital adrenal hyperplasia (19), we have used the same chemiluminescence method here, with bis(2,4,6-trichlorophenyl)oxalate-ANS used in measuring the label enzyme, glucose oxidase.
EIAs for haptens such as steroids, drugs, and T4 may be "homologous" (in which the same derivatives of the hapten are used both for preparing the hapten derivative-carrier protein and the hapten-enzyme conjugate) or "heterologous" (in which different hapten derivatives, bridge or site, are used). Van Weemen and Schuurs (20) suggested that the sensitivity of EJA for estrogen could be considerably improved by using heterologous systems. Hosoda et al. (21) systematically examined many steroid derivatives and antisera to them and reached the same conclusion. Miyai et al. (7) similarly reported significant displacement when they used a T4-alkaline phosphatase conjugate prepared with glutaraldehyde and antiserum against T4-BSA prepared with carbodiimide (site-heterologous system); on the other hand, in the ELA system involving a T4-alkaline phosphatase conjugate prepared with carbodiimide (homologous system), there was no significant displacement with T4, even in the presence of sufficient binding of T4-alkaline phosphatase conjugate to anti-T4 antiserum. Reported EIAs for T4 involving horseradish peroxidase (9) and -ri-galactosidase (10) were also site-heterologous systems. Therefore, we examined homologous and heterologous combinations among four anti-T4 antisera and four T4-glucose oxidase conjugates.
Given the displacement results shown in Figure 1 and Table 1, T4-glucose oxidase prepared by glutaraldehyde seems to be the most effective label for reacting against every antisera prepared in this study. The order of the displacement reactivities of T4-glucose oxidase against the anti-T4 antisera paralleled the order of the antisera affinities measured by RIA. The specificities of bridge-heterologous system and site-heterologous system were examined. As shown in Table 2 , the remarkable cross reaction with Dthyroxin seems inevitable, and both T4-glucose oxidases showed nearly the same cross reactivities with other T4-related compounds. Although 3,3'-triiodo-L-thyronine showed high cross reactivity, it may not exert any significant influence on the determination ofT4 in dried blood or plasma samples, its usual concentration in serum being about 1/70 of that of T4. Therefore, both EJA systems seem to be highly specific for T4.
The steepest portion of the standard curve ( Figure 2 ) is in the hypothyroid range between 10 and 100 pg of T4 per liter, where as little as 2.5 pg of T4 per liter can be detected reliably. This is sufficient sensitivity for use in large-scale screening for congenital hypothyroidism because the T4 cutoff value for hypothyroidism is less than 2 SD from the mean value for daily T4, which is <67 pg/L as measured with a Micromedic T4 RIA kit (22). The detection limit forT4 in dried blood samples is below the limits described for various RIA methods (23) and for the fluorescence EJA (12). The difference in results by the chemiluminescence assay and by RIA is due to the different expression of T4 concentrations in the T4 standard discs. The RIA values are in terms of serum T4 whereas the EJA T4 standards are reported in terms of whole blood; the former values are about twice the latter, both theoretically and in practice.
